First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet
Rituximab - Wikipedia
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect
Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology
The importance of continuing with RITUXAN® (rituximab) for RA Patients
Rituxan Side Effects - HRF
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet Respiratory Medicine
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group - ScienceDirect
PDF) Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders
immediate and long-term side effects of rituximab administration | Download Table
Side Effects of Rituximab for Cold Agglutinin Disease (CAD)
Cardiac side effect of rituximab Patil VB, Lunge SB, Doshi BR - Indian J Drugs Dermatol
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology Nurse Advisor
Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse | The Permanente Journal
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
GPA & MPA | RITUXAN® (rituximab) Safety on Follow Up Treatment
